NFA
UTHR icon

Nationwide Fund Advisors’s United Therapeutics UTHR Stock Holding History

Nationwide Fund Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-112,986
Closed -$13.2M – 2011
2017
Q3 		$13.2M Sell
112,986
-8,468
-7% -$1.08M 0.05% 493
2017
Q2 		$15.8M Buy
121,454
+11,586
+11% +$1.45M 0.06% 425
2017
Q1 		$14.9M Buy
109,868
+5,789
+6% +$877K 0.06% 464
2016
Q4 		$14.9M Sell
104,079
-22,883
-18% -$2.92M 0.06% 428
2016
Q3 		$15M Sell
126,962
-72,964
-36% -$8.77M 0.06% 429
2016
Q2 		$21.2M Buy
199,926
+17,645
+10% +$1.97M 0.09% 257
2016
Q1 		$20.3M Buy
182,281
+33,357
+22% +$4.22M 0.09% 271
2015
Q4 		$23.3M Buy
148,924
+76,279
+105% +$11.1M 0.1% 235
2015
Q3 		$9.53M Sell
72,645
-26,774
-27% -$4.29M 0.04% 549
2015
Q2 		$17.3M Sell
99,419
-7,016
-7% -$1.26M 0.07% 342
2015
Q1 		$18.4M Buy
106,435
+11,328
+12% +$1.73M 0.07% 336
2014
Q4 		$12.3M Sell
95,107
-6,361
-6% -$820K 0.05% 461
2014
Q3 		$13.1M Buy
101,468
+28,392
+39% +$2.93M 0.06% 445
2014
Q2 		$6.47M Sell
73,076
-4,256
-6% -$409K 0.03% 835
2014
Q1 		$7.27M Sell
77,332
-1,862
-2% -$190K 0.03% 688
2013
Q4 		$8.96M Sell
79,194
-61,036
-44% -$5.5M 0.04% 622
2013
Q3 		$11.1M Sell
140,230
-23,076
-14% -$1.69M 0.05% 482
2013
Q2 		$10.7M Buy
+163,306
New +$10.5M 0.06% 427

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nationwide Fund Advisors's UTHR Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of United Therapeutics (UTHR) in Q4 2017, closing a stake of 112,986 shares — an estimated $13.2M sold.

Nationwide Fund Advisors first reported a position in UTHR in Q2 2013 and held it in 18 quarters. The position peaked at $23.3M in Q4 2015. 400 funds tracked by Wall St. Rank hold UTHR as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining United Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 112,986 United Therapeutics shares in Q4 2017, an estimated $13.2M.
  • Nationwide Fund Advisors first reported a position in United Therapeutics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's United Therapeutics position peaked at $23.3M in Q4 2015.
  • 400 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.